predicting the outcome for patients with myelofibrosis undergoingi an allogenic hemopoietic stem cell transplant

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Several predictive scores have been described for patients with myelofibrosis (MF): these include IPSS [1], DIPPS [2], MYSEC [3], MIPSS [4] and GIPSS [5]. All of these have in common the identification of clinical, and biological risk factors for evolution of the disease and death. When these prognostic scores are applied to patients undergoing a hemopoietic stem cell transplant (HSCT), the outcome reflects the progression of the disease: patients with an early disease, always do better than patients with more advanced disease, and/or a higher risk score
Lingua originaleEnglish
pagine (da-a)111-111
Numero di pagine1
RivistaBlood Cancer Journal
Stato di pubblicazionePubblicato - 2022

Keywords

  • predicting the outcome for patients with myelofibrosis

Fingerprint

Entra nei temi di ricerca di 'predicting the outcome for patients with myelofibrosis undergoingi an allogenic hemopoietic stem cell transplant'. Insieme formano una fingerprint unica.

Cita questo